Glibenclamide for the Treatment of Acute CNS Injury

First introduced into clinical practice in 1969, glibenclamide (US adopted name, glyburide) is known best for its use in the treatment of diabetes mellitus type 2, where it is used to promote the release of insulin by blocking pancreatic K(ATP) [sulfonylurea receptor 1 (Sur1)-Kir6.2] channels. Durin...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kurland, David B., Tosun, Cigdem, Pampori, Adam, Karimy, Jason K., Caffes, Nicholas M., Gerzanich, Volodymyr, Simard, J. Marc
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2013
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3817601/
https://ncbi.nlm.nih.gov/pubmed/24275850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph6101287
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller